Emerging Market Funds Underweight On India, Says Citi
After meeting more than 30 investors in the US, Citi Research noted one major thing in common. Most of the emerging-market funds are underweight on Indian markets, which is in sharp contrast to its meeting conclusion last year, when everyone preferred India. It's the biggest underweight position by the EM funds, according to the New York-headquartered investment bank.
However, EM funds' most bearish view on Indian equities in 20 years does indicate a starting point for position, as growth starts to recover, Citi Research said.
This bearish view came a week after Citi Research upgraded India to overweight. As of now, a lot of questions rose regarding this view. The investment bank figured the key risks to Indian equities is a prolonged recovery, uncertainty in global markets weighing on external demand and private capex recovery. Risk-off sentiment in the global set up weighing on domestic flows is also among them, Citi Research said.
Domestic flows into Indian capital markets remained resilient at a time when foreign fund outflows amounted to $25 billion since October 2024, the brokerage said. Domestic institutional investors invested $36 billion during the same period. What'll be the flow outlook in near future is hard to predict, Citi Research said. The investment banker will be watchful of the trends.
Citi Research's constructive view is based on GDP and earnings recovery. The slowdown in Indian markets is cyclical and a gradual recovery is underway, according to the brokerage. Among reasons for this is a pick-up in government capex in December 2024 and January 2025. Personal tax incentives announced in the union budget, and the RBI taking liquidity measures, and normalising risk-weight on banks' NBFC and MFI credit are also reasons. The central bank also reduced the repo rate in its February meeting, Citi noted.
RBI is expected to cut repo rate two times by June.Citi Research
Earnings growth will likely be a good catalyst for any investors who are waiting to be exposed to India. Financials, insurance, healthcare, and telecom are Citi's preferred segments.
The brokerage is cautious on Indian IT sector. Recovery pace will not be smooth after guidance from Capegemini, EPAM System Inc., and Globant, it said.
The NSE Nifty IT's 7% year-to-date fall shocked most traders. The index declined despite Rupee depreciation and defensive perception about IT sector, Citi Research said.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.